Clinical Trial Update: Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated High- or High-Intermediate-Risk Diffuse Large B-Cell Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating rituximab in combination with chemotherapy for untreated high- or high-intermediate-risk diffuse large B-cell lymphoma has been withd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Rituxan (rituximab)

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma | Phase 2 | Status: WITHDRAWN